Worldwide eczema study aims to uncover disparities in care

NCT ID NCT07659756

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This international study observes how people with atopic dermatitis (eczema) access healthcare, what treatments they receive, and how the disease affects their daily lives. Researchers will collect data from routine medical records of about 9,600 participants across multiple countries. The goal is to identify differences in care and outcomes that could lead to better, more equitable treatment for everyone with eczema.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

This study could reveal gaps in care and help improve treatment strategies for people with eczema worldwide.

What could go wrong

As an observational study, it does not test a new treatment, so it cannot directly lead to a cure or new therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Zurich

    RECRUITING

    Zurich, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••